Suchergebnisse - "De Meerleer, Gert"

PubPharm (9)

1

ARNEO : A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

enthalten in: European urology | 2023

von Devos, G. | Tosco, L. | Baldewijns, M. | +15

CommentIn: Nat Rev Urol. 2022 Nov;19(11):634. - PMID 36195722

2

Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer : First Results from the Multicenter Phase 3 PROPER Trial

enthalten in: European urology focus | 2023

von Fonteyne, V. | Van Praet, C. | Ost, P. | +8

3

Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy

enthalten in: European urology oncology | 2021

von Martini, A. | Fossati, N. | Karnes, R. | +22

4

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2019

von Rammant, E. | Ost, P. | Swimberghe, M. | +8

5

The EMPaCT Classifier : A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis

enthalten in: European urology focus | 2018

von Tosco, L. | Laenen, A. | Briganti, A. | +24

6

4 Weeks Versus 5 Weeks of Hypofractionated High-dose Radiation Therapy as Primary Therapy for Prostate Cancer : Interim Safety Analysis of a Randomized Phase 3 Trial

enthalten in: International journal of radiation oncology, biology, physics | 2018

von Fonteyne, V. | Sarrazyn, C. | Swimberghe, M. | +9

7

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Ost, P. | Reynders, D. | Decaestecker, K. | +15

CommentIn: J Clin Oncol. 2018 Feb 10;36(5):435-437. - PMID 29240543

8

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP) : study protocol for a randomized phase II trial

enthalten in: BMC cancer | 2014

von Decaestecker, K. | De Meerleer, G. | Ameye, F. | +10

9

Improving positioning in high-dose radiotherapy for prostate cancer : safety and visibility of frequently used gold fiducial markers

enthalten in: International journal of radiation oncology, biology, physics | 2012

von Fonteyne, V. | Ost, P. | Villeirs, G. | +5

1
[1]